# Reddit, Inc.: financial statements, quarterly RDDT · NYSE · CIK 1713445 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rddt.md) · [Financials](/companies/rddt/financials.md) · [Filings](/companies/rddt/filings.md) · [Insiders](/companies/rddt/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rddt/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [250 d](/filings/0001713445-26-000022.md) | [243](/filings/0001713445-25-000102.md) | [281](/filings/0001713445-25-000196.md) | [348](/filings/0001713445-25-000227.md) | [428 d](/filings/0001713445-26-000022.md) | [392](/filings/0001713445-26-000069.md) | [500](/filings/0001713445-26-000100.md) | [585](/filings/0001713445-26-000116.md) | [726 d](/filings/0001713445-26-000022.md) | [663](/filings/0001713445-26-000069.md) | [805](/filings/0001713445-26-000100.md) | [895](/filings/0001713445-26-000116.md) | | Cost of revenue | $m | [28.9 d](/filings/0001713445-26-000022.md) | [27.6](/filings/0001713445-25-000102.md) | [29.5](/filings/0001713445-25-000196.md) | [34.6](/filings/0001713445-25-000227.md) | [31.8 d](/filings/0001713445-26-000022.md) | [37.1](/filings/0001713445-26-000069.md) | [45.9](/filings/0001713445-26-000100.md) | [52.5](/filings/0001713445-26-000116.md) | [58.7 d](/filings/0001713445-26-000022.md) | [56.3](/filings/0001713445-26-000069.md) | [70.3](/filings/0001713445-26-000100.md) | [75.8](/filings/0001713445-26-000116.md) | | Research and development | $m | [112 d](/filings/0001713445-26-000022.md) | [437](/filings/0001713445-25-000102.md) | [143](/filings/0001713445-25-000196.md) | [167](/filings/0001713445-25-000227.md) | [189 d](/filings/0001713445-26-000022.md) | [191](/filings/0001713445-26-000069.md) | [197](/filings/0001713445-26-000100.md) | [196](/filings/0001713445-26-000116.md) | [199 d](/filings/0001713445-26-000022.md) | [207](/filings/0001713445-26-000069.md) | [231](/filings/0001713445-26-000100.md) | [264](/filings/0001713445-26-000116.md) | | Operating income | $m | [3.0 d](/filings/0001713445-26-000022.md) | [(589)](/filings/0001713445-25-000102.md) | [(31.0)](/filings/0001713445-25-000196.md) | [6.9](/filings/0001713445-25-000227.md) | [52.9 d](/filings/0001713445-26-000022.md) | [3.9](/filings/0001713445-26-000069.md) | [67.7](/filings/0001713445-26-000100.md) | [139](/filings/0001713445-26-000116.md) | [232 d](/filings/0001713445-26-000022.md) | [183](/filings/0001713445-26-000069.md) | [232](/filings/0001713445-26-000100.md) | [262](/filings/0001713445-26-000116.md) | | Income tax | $m | [0.9 d](/filings/0001713445-26-000022.md) | [0.4](/filings/0001713445-25-000102.md) | [(0.2)](/filings/0001713445-25-000196.md) | [(0.0)](/filings/0001713445-25-000227.md) | [(1.0) d](/filings/0001713445-26-000022.md) | [(1.7)](/filings/0001713445-26-000069.md) | [(0.4)](/filings/0001713445-26-000100.md) | [(2.1)](/filings/0001713445-26-000116.md) | [3.2 d](/filings/0001713445-26-000022.md) | [1.7](/filings/0001713445-26-000069.md) | [4.0](/filings/0001713445-26-000100.md) | [5.8](/filings/0001713445-26-000116.md) | | Net income | $m | [18.5 d](/filings/0001713445-26-000022.md) | [(575)](/filings/0001713445-25-000102.md) | [(10.1)](/filings/0001713445-25-000196.md) | [29.9](/filings/0001713445-25-000227.md) | [71.0 d](/filings/0001713445-26-000022.md) | [26.2](/filings/0001713445-26-000069.md) | [89.3](/filings/0001713445-26-000100.md) | [163](/filings/0001713445-26-000116.md) | [252 d](/filings/0001713445-26-000022.md) | [204](/filings/0001713445-26-000069.md) | [253](/filings/0001713445-26-000100.md) | [283](/filings/0001713445-26-000116.md) | | Diluted EPS | $ per share | not reported | [(8.19)](/filings/0001713445-25-000102.md) | [(0.06)](/filings/0001713445-25-000196.md) | [0.16](/filings/0001713445-25-000227.md) | not reported | [0.13](/filings/0001713445-26-000069.md) | [0.45](/filings/0001713445-26-000100.md) | [0.80](/filings/0001713445-26-000116.md) | not reported | [1.01](/filings/0001713445-26-000069.md) | [1.25](/filings/0001713445-26-000100.md) | [1.40](/filings/0001713445-26-000116.md) | | Basic EPS | $ per share | not reported | [(8.19)](/filings/0001713445-25-000102.md) | [(0.06)](/filings/0001713445-25-000196.md) | [0.18](/filings/0001713445-25-000227.md) | not reported | [0.14](/filings/0001713445-26-000069.md) | [0.48](/filings/0001713445-26-000100.md) | [0.87](/filings/0001713445-26-000116.md) | not reported | [1.07](/filings/0001713445-26-000069.md) | [1.31](/filings/0001713445-26-000100.md) | [1.47](/filings/0001713445-26-000116.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [401](/filings/0001713445-26-000022.md) | [969](/filings/0001713445-25-000102.md) | [468](/filings/0001713445-25-000196.md) | [516](/filings/0001713445-25-000227.md) | [562](/filings/0001713445-26-000022.md) | [636](/filings/0001713445-25-000102.md) | [734](/filings/0001713445-25-000196.md) | [912](/filings/0001713445-25-000227.md) | [954](/filings/0001713445-26-000116.md) | [1,374](/filings/0001713445-26-000069.md) | [1,487](/filings/0001713445-26-000100.md) | [1,358](/filings/0001713445-26-000116.md) | | Current assets | $m | [1,480](/filings/0001713445-25-000018.md) | [1,920](/filings/0001713445-24-000006.md) | [1,981](/filings/0001713445-24-000054.md) | [2,061](/filings/0001713445-24-000102.md) | [2,223](/filings/0001713445-26-000022.md) | [2,329](/filings/0001713445-25-000102.md) | [2,530](/filings/0001713445-25-000196.md) | [2,770](/filings/0001713445-25-000227.md) | [3,136](/filings/0001713445-26-000116.md) | [3,386](/filings/0001713445-26-000069.md) | [3,542](/filings/0001713445-26-000100.md) | [3,857](/filings/0001713445-26-000116.md) | | Total assets | $m | [1,596](/filings/0001713445-25-000018.md) | [2,016](/filings/0001713445-24-000006.md) | [2,076](/filings/0001713445-24-000054.md) | [2,172](/filings/0001713445-24-000102.md) | [2,337](/filings/0001713445-26-000022.md) | [2,437](/filings/0001713445-25-000102.md) | [2,632](/filings/0001713445-25-000196.md) | [2,876](/filings/0001713445-25-000227.md) | [3,239](/filings/0001713445-26-000116.md) | [3,484](/filings/0001713445-26-000069.md) | [3,637](/filings/0001713445-26-000100.md) | [3,962](/filings/0001713445-26-000116.md) | | Current liabilities | $m | [134](/filings/0001713445-25-000018.md) | [156](/filings/0001713445-24-000006.md) | [160](/filings/0001713445-24-000054.md) | [172](/filings/0001713445-24-000102.md) | [176](/filings/0001713445-26-000022.md) | [187](/filings/0001713445-25-000102.md) | [211](/filings/0001713445-25-000196.md) | [228](/filings/0001713445-25-000227.md) | [271](/filings/0001713445-26-000116.md) | [266](/filings/0001713445-26-000069.md) | [338](/filings/0001713445-26-000100.md) | [357](/filings/0001713445-26-000116.md) | | Total liabilities | $m | [156](/filings/0001713445-25-000018.md) | [178](/filings/0001713445-24-000006.md) | [183](/filings/0001713445-24-000054.md) | [194](/filings/0001713445-24-000102.md) | [206](/filings/0001713445-26-000022.md) | [220](/filings/0001713445-25-000102.md) | [245](/filings/0001713445-25-000196.md) | [266](/filings/0001713445-25-000227.md) | [310](/filings/0001713445-26-000116.md) | [305](/filings/0001713445-26-000069.md) | [351](/filings/0001713445-26-000100.md) | [380](/filings/0001713445-26-000116.md) | | Shareholders' equity | $m | [(413)](/filings/0001713445-26-000022.md) | [1,838](/filings/0001713445-25-000196.md) | [1,894](/filings/0001713445-25-000227.md) | [1,978](/filings/0001713445-25-000227.md) | [2,131](/filings/0001713445-26-000116.md) | [2,217](/filings/0001713445-26-000100.md) | [2,387](/filings/0001713445-26-000116.md) | [2,611](/filings/0001713445-26-000116.md) | [2,929](/filings/0001713445-26-000116.md) | [3,180](/filings/0001713445-26-000100.md) | [3,286](/filings/0001713445-26-000116.md) | [3,582](/filings/0001713445-26-000116.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(17.4) d](/filings/0001713445-26-000022.md) | [32.1](/filings/0001713445-25-000102.md) | [28.4](/filings/0001713445-25-000196.md) | [71.6](/filings/0001713445-25-000227.md) | [90.0 d](/filings/0001713445-26-000022.md) | [128](/filings/0001713445-26-000069.md) | [111](/filings/0001713445-26-000100.md) | [185](/filings/0001713445-26-000116.md) | [267 d](/filings/0001713445-26-000022.md) | [312](/filings/0001713445-26-000069.md) | [262](/filings/0001713445-26-000100.md) | [364](/filings/0001713445-26-000116.md) | | Capital expenditure | $m | [4.6 d](/filings/0001713445-26-000022.md) | [2.9](/filings/0001713445-25-000102.md) | [1.2](/filings/0001713445-25-000196.md) | [1.4](/filings/0001713445-25-000227.md) | [0.8 d](/filings/0001713445-26-000022.md) | [1.0](/filings/0001713445-26-000069.md) | [0.5](/filings/0001713445-26-000100.md) | [2.1](/filings/0001713445-26-000116.md) | [3.2 d](/filings/0001713445-26-000022.md) | [1.1](/filings/0001713445-26-000069.md) | [1.1](/filings/0001713445-26-000100.md) | [1.2](/filings/0001713445-26-000116.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001713445-26-000069.md) | [0.0](/filings/0001713445-26-000100.md) | [0.0](/filings/0001713445-26-000116.md) | not reported | [5.0](/filings/0001713445-26-000069.md) | [235](/filings/0001713445-26-000100.md) | [100](/filings/0001713445-26-000116.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [58.1](/filings/0001713445-24-000006.md) | [58.5](/filings/0001713445-24-000054.md) | [58.9](/filings/0001713445-24-000102.md) | [70.2](/filings/0001713445-25-000102.md) | [164](/filings/0001713445-25-000196.md) | [192](/filings/0001713445-25-000227.md) | [201](/filings/0001713445-26-000069.md) | [200](/filings/0001713445-26-000100.md) | [203](/filings/0001713445-26-000116.md) | [203](/filings/0001713445-26-000069.md) | [202](/filings/0001713445-26-000100.md) | [202](/filings/0001713445-26-000116.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 13:58 ET. No prices; not investment advice.